1.Clinical characteristics in lymphangioleiomyomatosis-related pulmonary hypertension: an observation on 50 patients.
Xiuxiu WU ; Wenshuai XU ; Jun WANG ; Xinlun TIAN ; Zhuang TIAN ; Kaifeng XU
Frontiers of Medicine 2019;13(2):259-266
		                        		
		                        			
		                        			Lymphangioleiomyomatosis (LAM) is a rare diffuse cystic lung disease. Knowledge on LAM-related pulmonary hypertension (PH) is limited. This study aimed to analyze the clinical characteristics of LAM with elevated pulmonary artery pressure (PAP) and evaluate the potential efficacy of sirolimus. The study involved 50 LAM patients who underwent echocardiography. According to the tricuspid regurgitation velocity (TRV), these patients were divided into the TRV ⩽ 2.8 m/s group and TRV > 2.8 m/s group. Both groups comprised 25 females with an average age of 38.6 ± 8.1 and 41.5 ± 8.9 years. In the TRV > 2.8 m/s group, the estimated systolic PAP (SPAP) was significantly elevated (52.08 ± 12.45 mmHg vs. 30.24 ± 5.25 mmHg, P < 0.01). Linear analysis showed that SPAP was correlated with forced expiratory volume in 1 s (FEV), diffusing capacity of the lungs for carbon monoxide, alveolar arterial oxygen gradient (PO), and 6 min walking distance (r =-0.392, -0.351, 0.450, and -0.591, respectively; P < 0.05), in which PO was a risk factor for SPAP elevation (β = 0.064, OR = 1.066, P < 0.05). Moreover, in 10 patients who received sirolimus therapy, SPAP decreased from 57.0 12.6 mmHg to 35.2 ± 11.1 mmHg. The study showed that LAM patients with PH exhibit poor pulmonary function and hypoxemia and may benefit from sirolimus treatment.
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Carbon Monoxide
		                        			;
		                        		
		                        			analysis
		                        			;
		                        		
		                        			Echocardiography
		                        			;
		                        		
		                        			Exercise Test
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Hemodynamics
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hypertension, Pulmonary
		                        			;
		                        		
		                        			physiopathology
		                        			;
		                        		
		                        			therapy
		                        			;
		                        		
		                        			Logistic Models
		                        			;
		                        		
		                        			Lymphangioleiomyomatosis
		                        			;
		                        		
		                        			physiopathology
		                        			;
		                        		
		                        			therapy
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Multivariate Analysis
		                        			;
		                        		
		                        			Oxygen
		                        			;
		                        		
		                        			blood
		                        			;
		                        		
		                        			therapeutic use
		                        			;
		                        		
		                        			Respiratory Function Tests
		                        			;
		                        		
		                        			Sirolimus
		                        			;
		                        		
		                        			therapeutic use
		                        			
		                        		
		                        	
2.Carbon Monoxide Ameliorates 6-Hydroxydopamine-Induced Cell Death in C6 Glioma Cells.
Hyewon MOON ; Jung Hee JANG ; Tae Chang JANG ; Gyu Hwan PARK
Biomolecules & Therapeutics 2018;26(2):175-181
		                        		
		                        			
		                        			Carbon monoxide (CO) is well-known as toxic gas and intrinsic signaling molecule such as neurotransmitter and blood vessel relaxant. Recently, it has been reported that low concentration of CO exerts therapeutic actions under various pathological conditions including liver failure, heart failure, gastric cancer, and cardiac arrest. However, little has been known about the effect of CO in neurodegenerative diseases like Parkinson’s disease (PD). To test whether CO could exert a beneficial action during oxidative cell death in PD, we examined the effects of CO on 6-hydroxydopamine (6-OHDA)-induced cell death in C6 glioma cells. Treatment of CO-releasing molecule-2 (CORM-2) significantly attenuated 6-OHDA-induced apoptotic cell death in a dose-dependent manner. CORM-2 treatment decreased Bax/Bcl2 ratio and caspase-3 activity, which had been increased by 6-OHDA. CORM-2 increased phosphorylation of NF-E2-related factor 2 (Nrf2) which is a transcription factor regulating antioxidant proteins. Subsequently, CORM-2 also increased the expression of heme oxygenase-1 and superoxide dismutases (CuZnSOD and MnSOD), which were antioxidant enzymes regulated by Nrf2. These results suggest that CO released by CORM-2 treatment may have protective effects against oxidative cell death in PD through the potentiation of cellular adaptive survival responses via activation of Nrf2 and upregulation of heme oxygenase-1, leading to increasing antioxidant defense capacity.
		                        		
		                        		
		                        		
		                        			Blood Vessels
		                        			;
		                        		
		                        			Carbon Monoxide*
		                        			;
		                        		
		                        			Carbon*
		                        			;
		                        		
		                        			Caspase 3
		                        			;
		                        		
		                        			Cell Death*
		                        			;
		                        		
		                        			Glioma*
		                        			;
		                        		
		                        			Heart Arrest
		                        			;
		                        		
		                        			Heart Failure
		                        			;
		                        		
		                        			Heme Oxygenase-1
		                        			;
		                        		
		                        			Liver Failure
		                        			;
		                        		
		                        			Neurodegenerative Diseases
		                        			;
		                        		
		                        			Neuroprotection
		                        			;
		                        		
		                        			Neurotransmitter Agents
		                        			;
		                        		
		                        			NF-E2-Related Factor 2
		                        			;
		                        		
		                        			Oxidopamine
		                        			;
		                        		
		                        			Phosphorylation
		                        			;
		                        		
		                        			Stomach Neoplasms
		                        			;
		                        		
		                        			Superoxides
		                        			;
		                        		
		                        			Transcription Factors
		                        			;
		                        		
		                        			Up-Regulation
		                        			
		                        		
		                        	
3.Factors Related to Smoking Relapse among Military Personnel in Korea: Data from Smoking Cessation Clinics, 2015–2017
Korean Journal of Health Promotion 2018;18(3):138-146
		                        		
		                        			
		                        			BACKGROUND: Relapse is the common situation of smoking cessation attempts. There are few studies that analyzed the related factors of smoking relapse among military personnel. Thus, This study was performed to investigate factors related to smoking relapse among military personnel who participated smoking cessation clinics in Korea. METHODS: The study subjects were 19,874 military personnel who enrolled smoking cessation clinic from January in 2015 to December in 2017. Smoking cessation applied to criteria exhaled carbon monoxide and urine cotinine levels. Binominal logistic regression analysis was performed to confirm related factors of smoking relapse among military personnel who succeed to quit smoking. RESULTS: The smoking relapse rate of study subjects who succeeded in quitting smoking for 1-month was 15.3% after 3-months and 60.8% after 6-months follow-up. The factors associated with relapse smoking included implementing year, past year quit attempts, number or cigarettes smoked per day, regular exercise, blood pressure. Levels of nicotine dependence affected smoking relapse at 3-months follow-up. CONCLUSIONS: Tailored approaches are necessary to reduce the rates of smoking relapse for military personnel who succeeded to quit smoking shortly but relapse back to smoking.
		                        		
		                        		
		                        		
		                        			Blood Pressure
		                        			;
		                        		
		                        			Carbon Monoxide
		                        			;
		                        		
		                        			Cotinine
		                        			;
		                        		
		                        			Follow-Up Studies
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Korea
		                        			;
		                        		
		                        			Logistic Models
		                        			;
		                        		
		                        			Military Personnel
		                        			;
		                        		
		                        			Recurrence
		                        			;
		                        		
		                        			Smoke
		                        			;
		                        		
		                        			Smoking Cessation
		                        			;
		                        		
		                        			Smoking
		                        			;
		                        		
		                        			Tobacco Products
		                        			;
		                        		
		                        			Tobacco Use Disorder
		                        			
		                        		
		                        	
4.Neutrophil-to-lymphocyte Ratio in Diagnosis of Systemic Sclerosis for Prediction of Interstitial Lung Disease.
Ji Hyeon JUNG ; Yu Mi LEE ; Eun Gyeong LEE ; Wan Hee YOO ; Won Seok LEE
Journal of Rheumatic Diseases 2017;24(3):138-142
		                        		
		                        			
		                        			OBJECTIVE: The neutrophil-to-lymphocyte ratio (NLR) is elevated in inflammatory diseases, but its clinical significance in systemic sclerosis (SSc) is unclear. This study evaluated NLR in diagnosing SSc and in predicting lung involvement such as interstitial lung disease (ILD). METHODS: The medical records of 88 patients with SSc and 50 healthy controls were reviewed. Exclusion criteria included active infection or the presence of any hematological, cardiovascular, or metabolic disorder. The NLR was compared between patients with SSc and healthy controls, and associations between NLR and lung involvement were analyzed. RESULTS: The NLR was significantly higher in patients with SSc compared to healthy controls (NLR, 3.95±6.59 vs. 2.00±1.07, p<0.01). Patients with SSc and ILD had higher NLR levels than those without ILD (p<0.01, p<0.05). NLR was negatively associated with forced vital capacity (r=−0.341, p<0.01), but not with diffusing capacity for carbon monoxide. Receiver-operating characteristics analysis of NLR to predict ILD in patients with SSc showed that the area under the curve was 0.763. The cut-off NLR value for prediction of lung involvement was determined to be 2.59 (sensitivity, 0.700; specificity, 0.729; p<0.01). CONCLUSION: NLR may be a promising marker that reflects ILD in patients with SSc, and values greater than 2.59 were useful in predicting ILD.
		                        		
		                        		
		                        		
		                        			Blood Platelets
		                        			;
		                        		
		                        			Carbon Monoxide
		                        			;
		                        		
		                        			Diagnosis*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Lung
		                        			;
		                        		
		                        			Lung Diseases, Interstitial*
		                        			;
		                        		
		                        			Lymphocytes
		                        			;
		                        		
		                        			Medical Records
		                        			;
		                        		
		                        			Neutrophils
		                        			;
		                        		
		                        			Scleroderma, Systemic*
		                        			;
		                        		
		                        			Sensitivity and Specificity
		                        			;
		                        		
		                        			Vital Capacity
		                        			
		                        		
		                        	
5.Risk Factors Associated with Rhabdomyolysis in Acute Carbon Monoxide Poisoning.
Gio HAN ; Yeon Sik JANG ; Jae Ho JANG ; Yong Su LIM ; Hyuk Jun YANG
Journal of Korean Burn Society 2016;19(2):67-72
		                        		
		                        			
		                        			PURPOSE: The aim of this study was to determine the risk factors for rhabdomyolysis in patients with carbon monoxide (CO) poisoning. METHODS: This was a retrospective study on patients with CO poisoning who visited the emergency department from January 1, 2014 to December 31, 2015. We compared clinical variables between patients with and without rhabdomyolysis. RESULTS: Among 120 patients who were included to this study, 108 patients exhibited normal value of CPK (creatine phosphokinase), and 12 patients were diagnosed as rhabdomyolysis. Sources of CO, duration of CO exposure, initial GCS (Grasgow coma scale), initial systolic and diastolic blood pressure, initial body temperature and AKI (Acute kidney injury) were showed significant difference between patients who developed rhabdomyolysis and patients who did not. In addition, initial white blood cell counts, troponin I level and carboxyhemoglobin (COHb) level were more higher in rhabdomyolysis group. pH and initial bicarbonate level were more lower. Duration of CO exposure (Odds ratio, 1.011; 95% confidence interval, 1.002∼1.020, P=0.021)was found to be only risk factor for rhabdomyolysis by logistic regression analysis. CONCLUSION: Duration of CO exposure is potential risk factor of rhabdomyolysis development in CO poisoning.
		                        		
		                        		
		                        		
		                        			Blood Pressure
		                        			;
		                        		
		                        			Body Temperature
		                        			;
		                        		
		                        			Carbon Monoxide Poisoning*
		                        			;
		                        		
		                        			Carbon Monoxide*
		                        			;
		                        		
		                        			Carbon*
		                        			;
		                        		
		                        			Carboxyhemoglobin
		                        			;
		                        		
		                        			Coma
		                        			;
		                        		
		                        			Emergency Service, Hospital
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hydrogen-Ion Concentration
		                        			;
		                        		
		                        			Kidney
		                        			;
		                        		
		                        			Leukocyte Count
		                        			;
		                        		
		                        			Logistic Models
		                        			;
		                        		
		                        			Poisoning
		                        			;
		                        		
		                        			Reference Values
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Rhabdomyolysis*
		                        			;
		                        		
		                        			Risk Factors*
		                        			;
		                        		
		                        			Troponin I
		                        			
		                        		
		                        	
6.Elevated Erythrocyte Sedimentation Rate Is Predictive of Interstitial Lung Disease and Mortality in Dermatomyositis: a Korean Retrospective Cohort Study.
Dong Jin GO ; Eun Young LEE ; Eun Bong LEE ; Yeong Wook SONG ; Maximilian Ferdinand KONIG ; Jin Kyun PARK
Journal of Korean Medical Science 2016;31(3):389-396
		                        		
		                        			
		                        			Interstitial lung disease (ILD) is a major cause of death in patients with dermatomyositis (DM). This study was aimed to examine the utility of the erythrocyte sedimentation rate (ESR) as a predictor of ILD and prognostic marker of mortality in patients with DM. One hundred-and-fourteen patients with DM were examined, including 28 with clinically amyopathic DM (CADM). A diagnosis of ILD was made based on high resolution computed tomography (HRCT) scans. The association between elevated ESR and pulmonary impairment and mortality was then examined. ILD was diagnosed in 53 (46.5%) of 114 DM patients. Cancer was diagnosed in 2 (3.8%) of 53 DM patients with ILD and in 24 (92.3%) of those without ILD (P < 0.001). The median ESR (50.0 mm/hour) in patients with ILD was significantly higher than that in patients without ILD (29.0 mm/hour; P < 0.001). ESR was inversely correlated with forced vital capacity (Spearman rho = - 0.303; P = 0.007) and carbon monoxide diffusing capacity (rho = - 0.319; P = 0.006). DM patients with baseline ESR > or = 30 mm/hour had significantly higher mortality than those with ESR < 30 mm/hour (P = 0.002, log-rank test). Patients with a persistently high ESR despite immunosuppressive therapy was associated with higher mortality than those with a normalized ESR (P = 0.039, log-rank test). Elevated ESR is associated with increased mortality in patients with DM due to respiratory failure. Thus, monitoring ESR should be an integral part of the clinical care of DM patients.
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Asian Continental Ancestry Group
		                        			;
		                        		
		                        			Blood Sedimentation
		                        			;
		                        		
		                        			Carbon Monoxide/metabolism
		                        			;
		                        		
		                        			Cohort Studies
		                        			;
		                        		
		                        			Dermatomyositis/blood/*diagnosis/mortality
		                        			;
		                        		
		                        			Disease Progression
		                        			;
		                        		
		                        			Erythrocytes/*cytology
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Follow-Up Studies
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Immunosuppressive Agents/therapeutic use
		                        			;
		                        		
		                        			Lung Diseases, Interstitial/*complications/diagnosis
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Predictive Value of Tests
		                        			;
		                        		
		                        			Prognosis
		                        			;
		                        		
		                        			Republic of Korea
		                        			;
		                        		
		                        			Respiratory Function Tests
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Risk Factors
		                        			;
		                        		
		                        			Survival Analysis
		                        			
		                        		
		                        	
7.Changes of HbCO in the Blood of Rats with Different CO Concentration and Inhalation Time.
Qing CHEN ; Jie BAI ; Chang Rong LI ; Wen Fang ZHANG
Journal of Forensic Medicine 2016;32(6):410-412
		                        		
		                        			OBJECTIVES:
		                        			To explore the change rules of behavioral characteristics, survival time and saturation of carboxyhemoglobin (HbCO) in different CO concentration to provide experimental basis for the cases of CO poisoning death in forensic practice.
		                        		
		                        			METHODS:
		                        			Total 160 SD rats were randomly divided into four groups. CO with the concentration of 1 250 mg/m³, 3 750 mg/m³, 6 250 mg/m³ were continuously and respectively replenished in a self-made toxicant exposure equipment until rats died from poisoning. In different CO concentration, the behavioral characteristics and survival time of poisoning rats were observed and recorded. The saturation of HbCO in heart blood was detected by spectrophotometric method. Organs such as brain, heart, lung and liver, and heart blood were obtained via autopsy and histopathological observation was performed.
		                        		
		                        			RESULTS:
		                        			The behavioral characteristics of CO poisoning rats were limp and slow response. There were a gradual decrease of survival time and an increase of HbCO saturation in rats with the increase of CO concentration. Three rats in CO concentration of 1 250 mg/m³ group showed lower saturations of HbCO than the lethal dose and this situation hasn't been found in other groups.
		                        		
		                        			CONCLUSIONS
		                        			The animal model of CO poisoning established under different CO concentration has the advantages such as simplicity and good repeatability, which lays a foundation to the further study for CO and other inhaled toxic gas in the research of forensic sciences.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Carbon Monoxide Poisoning/blood*
		                        			;
		                        		
		                        			Carboxyhemoglobin/analysis*
		                        			;
		                        		
		                        			Disease Models, Animal
		                        			;
		                        		
		                        			Dose-Response Relationship, Drug
		                        			;
		                        		
		                        			Rats
		                        			;
		                        		
		                        			Rats, Sprague-Dawley
		                        			
		                        		
		                        	
8.A Case of Rhabdomyolysis Presenting with Acute Kidney Injury Complicating Carbon Monoxide Poisoning.
Sin Young NHO ; In Hee LEE ; Ki Sung AHN ; Dae Seong HYEON ; Gun Woo KANG
Korean Journal of Medicine 2015;89(4):461-464
		                        		
		                        			
		                        			Carbon monoxide (CO) poisoning has increased rapidly in South Korea and may cause a variety of clinical effects. The most common complications are neurologic and neuropsychological disturbances. However, in rare cases, CO poisoning may also be associated with acute kidney injury and non-traumatic rhabdomyolysis. Here, we report a case of acute kidney injury and rhabdomyolysis complicating CO poisoning. A 32-year-old woman was admitted to our emergency department with dyspnea and confused consciousness after exposure to CO during a suicide attempt involving charcoal briquettes. Laboratory findings revealed a carboxyhemoglobin (COHb) level of 44.8%, a blood urea nitrogen level of 20.5 mg/dL, a serum creatinine level of 1.4 mg/dL, and a creatine phosphokinase level of 8,688.3 IU/L. Acute kidney injury and rhabdomyolysis complicating CO poisoning were diagnosed. This case was managed with normobaric oxygen therapy and hydration. The patient recovered completely with respect to renal function and muscle enzyme level, and COHb level returned to 0%.
		                        		
		                        		
		                        		
		                        			Acute Kidney Injury*
		                        			;
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Blood Urea Nitrogen
		                        			;
		                        		
		                        			Carbon Monoxide Poisoning*
		                        			;
		                        		
		                        			Carbon Monoxide*
		                        			;
		                        		
		                        			Carbon*
		                        			;
		                        		
		                        			Carboxyhemoglobin
		                        			;
		                        		
		                        			Charcoal
		                        			;
		                        		
		                        			Consciousness
		                        			;
		                        		
		                        			Creatine Kinase
		                        			;
		                        		
		                        			Creatinine
		                        			;
		                        		
		                        			Dyspnea
		                        			;
		                        		
		                        			Emergency Service, Hospital
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Korea
		                        			;
		                        		
		                        			Oxygen
		                        			;
		                        		
		                        			Poisoning
		                        			;
		                        		
		                        			Rhabdomyolysis*
		                        			;
		                        		
		                        			Suicide
		                        			
		                        		
		                        	
9.Therapeutic effect of hemin on gestational hypertension in rats and the mechanism.
Mai-Lian LONG ; Ai-Bin XIA ; Chun-Xia CHENG ; Rui-Zhen LI
Journal of Southern Medical University 2015;35(4):583-586
OBJECTIVETo investigate the therapeutic effects of hemin, an inducer of heme oxygenase, in a rat model of gestational hypertension and explore the possible mechanism.
METHODSEighteen pregnant SD rats at day 12 of gestation were randomized equally into gestational hypertension model group, hemin treatment group, and normal pregnancy (control) group. In the former two groups, the rats were subjected to daily nitro-L-arginine methyl ester (L-NAME, 80 mg/kg) gavage since gestational day 14 for 7 consecutive days to induce gestational hypertension; saline was administered in the same manner in the control rats. The rats in hemin group received daily intraperitoneal injection of hemin (30 mg/kg) starting from gestational day 16. HO activity and carboxyhemoglobin (COHb) level in rat placental tissue were detected with spectrophotometric method, and soluble vascular endothelial growth factor receptor-1 (sFlt-1) and vascular endothelial growth factor (VEGF) level in the placental tissue homogenate supernatant were detected using ELSIA.
RESULTSAt gestational day 20, the blood pressure and 24-h urinary protein were significantly higher in the model group than in the other two groups (P<0.05), and were higher in hemin group than in the control group (P<0.05); HO activity and COHb content in the placenta tissue were the lowest in the model group (P<0.05), and was lower in hemin group than in the control group (P<0.05). The level of sFlt-1 was significantly higher and VEGF level significantly lower in the model group than in the other two groups (P<0.05); sFlt-1 level remained higher and VEGF lower in hemin group than in the control group (P<0.05).
CONCLUSIONHemin can reduce blood pressure and urinary protein in rats with gestational hypertension possibly by up-regulating HO activity, enhancing carbon monoxide production, reducing sFlt-1 and increasing VEGF in the placental tissue.
Animals ; Blood Pressure ; Carbon Monoxide ; metabolism ; Disease Models, Animal ; Female ; Heme Oxygenase (Decyclizing) ; Hemin ; pharmacology ; Hypertension, Pregnancy-Induced ; drug therapy ; Placenta ; drug effects ; metabolism ; Pregnancy ; Rats ; Rats, Sprague-Dawley ; Vascular Endothelial Growth Factor A ; metabolism ; Vascular Endothelial Growth Factor Receptor-1 ; metabolism
10.Cerebrovascular ischaemia after carbon monoxide intoxication.
Hasan KARA ; A BAYIR ; Ahmet AK ; Selim DEGIRMENCI
Singapore medical journal 2015;56(2):e26-8
		                        		
		                        			
		                        			Carbon monoxide intoxication is the most prevalent cause of death from carbon monoxide poisoning. We herein report the case of a 56-year-old man who was found unconscious and smelled of smoke after exposure to carbon monoxide from a heater. He scored 5 on the Glasgow Coma Scale, and had respiratory insufficiency and elevated troponin I, creatine kinase-MB fraction and carboxyhaemoglobin levels. He was treated by mechanical ventilation. After regaining consciousness, brain magnetic resonance imaging showed diffusion restriction in the left occipital lobe; there was a loss of vision (right temporal hemianopsia), which improved by the follow-up session. Carbon monoxide intoxication may cause neurologic and cardiac sequelae, and the initial treatment includes oxygen therapy. Acute carbon monoxide poisoning can cause serious injury to the brain, heart and other organs; the most severe damages that could be inflicted to the brain include cerebral ischaemia and hypoxia, oedema, and neural cell degeneration and necrosis.
		                        		
		                        		
		                        		
		                        			Brain
		                        			;
		                        		
		                        			physiopathology
		                        			;
		                        		
		                        			Brain Ischemia
		                        			;
		                        		
		                        			physiopathology
		                        			;
		                        		
		                        			Carbon Monoxide
		                        			;
		                        		
		                        			chemistry
		                        			;
		                        		
		                        			Carbon Monoxide Poisoning
		                        			;
		                        		
		                        			physiopathology
		                        			;
		                        		
		                        			Carboxyhemoglobin
		                        			;
		                        		
		                        			chemistry
		                        			;
		                        		
		                        			Creatine Kinase, MB Form
		                        			;
		                        		
		                        			blood
		                        			;
		                        		
		                        			Diffusion
		                        			;
		                        		
		                        			Glasgow Coma Scale
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hyperbaric Oxygenation
		                        			;
		                        		
		                        			Hypoxia
		                        			;
		                        		
		                        			Magnetic Resonance Imaging
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Myocardial Ischemia
		                        			;
		                        		
		                        			physiopathology
		                        			;
		                        		
		                        			Stroke
		                        			;
		                        		
		                        			physiopathology
		                        			;
		                        		
		                        			Troponin I
		                        			;
		                        		
		                        			blood
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail